Professor, Pediatrics, University of Washington School of Medicine
Pediatric Hematology & Oncology
Dr. Jean E. Sanders, MD
|
|
Give Review
Doctor Jean E. Sanders, MD is an expert in the field of Pediatric Hematology & Oncology. She attended University of Iowa Carver College of Medicine. University of Iowa Carver College of Medicine is ranked 29/16 in Research/PrimaryCare. Jean Sanders has written publications. She has 48 publications published with PubMed. The lastest publication is: 'Intestinal decontamination of multidrug-resistant Klebsiella pneumoniae after recurrent infections in an immunocompromised host.'
Publications
- Intestinal decontamination of multidrug-resistant Klebsiella pneumoniae after recurrent infections in an immunocompromised host.
- Allogeneic hematopoietic cell transplantation for neuroblastoma: the CIBMTR experience.
- Modulation of gene expression using electrospun scaffolds with templated architecture.
- Success of allogeneic marrow transplantation for children with severe aplastic anaemia.
- National Cancer Institute, National Heart, Lung and Blood Institute/Pediatric Blood and Marrow Transplantation Consortium First International Consensus Conference on L...
- NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: endocrine challenges-thyroid dysfunction, growth im...
- NCI, NHLBI first international consensus conference on late effects after pediatric hematopoietic cell transplantation: state of the science, future directions.
- Late effects among pediatric patients followed for nearly four decades after transplantation for severe aplastic anemia.
- Randomized Trial of Hydroxychloroquine for Newly Diagnosed Chronic Graft-versus-Host Disease in Children: A Children's Oncology Group Study.
- Unrelated donor bone marrow transplantation for myelodysplastic syndrome in children.
- Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus...
- Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation for high-risk hematologic malignancies.
- A Phase I/II Study of Chemotherapy Followed by Donor Lymphocyte Infusion plus Interleukin-2 for Relapsed Acute Leukemia after Allogeneic Hematopoietic Cell Transplanta...
- Analysis of the role of hematopoietic stem-cell transplantation in infants with acute lymphoblastic leukemia in first remission and MLL gene rearrangements: a report f...
- Increased cardiometabolic traits in pediatric survivors of acute lymphoblastic leukemia treated with total body irradiation.
- Hypertension in long-term survivors of pediatric hematopoietic cell transplantation.
- Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation.
- Hematopoietic stem cell transplantation for refractory or recurrent non-Hodgkin lymphoma in children and adolescents.
- Thyroid function following hematopoietic cell transplantation in children: 30 years' experience.
- Treatment change as a predictor of outcome among patients with classic chronic graft-versus-host disease.
- Sexual function changes during the 5 years after high-dose treatment and hematopoietic cell transplantation for malignancy, with case-matched controls at 5 years.
- Late effects following hematopoietic cell transplantation for children.
- HLA-matched related donor hematopoietic cell transplantation in 43 patients with Fanconi anemia conditioned with 60 mg/kg of cyclophosphamide.
- Hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: similar outcomes in patie...
- Bisphosphonate therapy for reduced bone mineral density in children with chronic graft-versus-host disease.
- Prophylactic administration of imatinib after hematopoietic cell transplantation for high-risk Philadelphia chromosome-positive leukemia.
- The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review.
- Pulmonary function in long-term survivors of pediatric hematopoietic cell transplantation.
- Role of allogeneic stem cell transplantation in FLT3/ITD-positive AML.
- Survival after recurrence of Ewing's sarcoma family of tumors.
- Allogeneic hematopoietic cell transplantation for infants with acute lymphoblastic leukemia.
- Final adult height of patients who received hematopoietic cell transplantation in childhood.
- Duration of immunosuppressive treatment for chronic graft-versus-host disease.
- Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma.
- Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation.
- Diagnosis and clinical management of chronic graft-versus-host disease.
- Fractionated low-dose radiotherapy after myeloablative stem cell transplantation for local control in patients with high-risk neuroblastoma.
- Diabetes mellitus in long-term survivors of pediatric hematopoietic cell transplantation.
- Allogeneic hematopoietic stem cell transplantation for myelofibrosis.
- Survival after second hematopoietic stem cell transplantation for recurrent pediatric acute myeloid leukemia.
- Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.
- Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic s...
- Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone.
- Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children.
- Morbidity and mortality of chronic GVHD after hematopoietic stem cell transplantation from HLA-identical siblings for patients with aplastic or refractory anemias.
- Psoralen and ultraviolet A irradiation (PUVA) as therapy for steroid-resistant cutaneous acute graft-versus-host disease.
- Telomere shortening in hematopoietic stem cell transplantation: a potential mechanism for late graft failure?
Schools
University of Ia Roy J amp L Carver Com
Doctors Specialties
- Pediatrics
- Pediatric Hematology
- Oncology
Accepted Insurances
Education
-
University of Iowa Carver College of Medicine
Hospital
-
Seattle Children's Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Bryan C. Dryer, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarah F. Munson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amelie O. Von Saint Andre-Von Arnim, MD |
|
|
Dr. Christopher J. Ng, MD |
|
|
Dr. Laura B. O'Neill, MD |
|
|
Dr. Phoenix A. Ho, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tina M. Albertson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Colleen S. Delaney, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric J. Chow, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rebecca A. Gardner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Barbara E. Small, MD |
|
|
Dr. Abby R. Rosenberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Douglas S. Hawkins, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Ronald S. Cheung, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Blythe Thomson, MD
This Doctor is OpenDoctor Recommended.
|